Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

glycopyrrolate

glycopyrrolate
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Seebri Neohaler CAPSULE, INHALATION 15.6 mcg    
Lonhala Magnair SOLUTION, INHALATION 25 mcg/ mL    
Robinul SOLUTION, INJECTABLE 0.2 mg/mL      
Cuvposa SOLUTION, ORAL 1 mg/5 mL    
Dartisla TABLET, DISINTEGRATING, ORAL 0.85 mg, 1.7 mg      
Robinul TABLET, ORAL 1 mg      
Robinul Forte TABLET, ORAL 2 mg      


Comments:

Due to national shortage of the nebulization solutions, the formulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products will automatically return to their original formulary status. See Albuterol/Duoneb Shortage Mitigation for more information. (Updated Feb 2023)

 


Cuvposa: Formulary status, Restricted to pediatrics.  For adults, automatic interchange to hyoscyamine liquid (hyoscyamine 0.125 mg is equivalent to glycopyrrolate 1 mg orally, and proportionately.)

Dartisla ODT: Non-formulary. Recommend alternative therapies for treatment of peptic ulcers (PPIs, H2RAs, Sucralfate). Inpatients may use home supply if alternatives not appropriate. Oral generic glycopyrrolate tablets may also be recommended.

  


ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

glycopyrrolate inhalation (Seebri Neohaler)

  • 15.6 mcg cap inhalation twice daily

ipratropium nebulization

  • 0.5 mg NEB every 6 hours

glycopyrrolate inhalation (Lonhala Magnair)

  • 25 mcg inhaled BID

 

ipratropium nebulization

  • 0.5 mg NEB QID

 

 


Reviewed: May 24, 2011 (Cuvposa), and 22 Set 2015 (Cuvposa), and 24 January 2017 (Seebri), and August 2020 (Lonhala Magnair), February 2024 (Dartisla ODT)

 

Glycopyrrolate (Dartisla ODT)

 


Last updated: Apr. 12, 2024







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.